BeyondSpring Inc. Defined Contribution Plan, Cost
BeyondSpring Inc. (BYSI) reported Defined Contribution Plan, Cost of $1.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2026-08-14
- BeyondSpring Inc. defined contribution plan, cost for the quarter ending 2026-06-30 was $1.00K, a 94.12% decline year-over-year.
- BeyondSpring Inc. defined contribution plan, cost for the quarter ending 2026-03-31 was $1.00K, a 93.75% decline year-over-year.
- BeyondSpring Inc. defined contribution plan, cost for the quarter ending 2025-12-31 was $2.00K, a 85.71% decline year-over-year.
- BeyondSpring Inc. defined contribution plan, cost for the quarter ending 2025-09-30 was $12.00K, a 25.00% decline year-over-year.
- BeyondSpring Inc. defined contribution plan, cost for fiscal 2025 was $47.00K, a 4.44% increase from fiscal 2024.
- BeyondSpring Inc. defined contribution plan, cost for fiscal 2024 was $45.00K, a 30.77% decline from fiscal 2023.
- BeyondSpring Inc. defined contribution plan, cost for fiscal 2023 was $65.00K.
| Period end | Defined Contribution Plan, Cost 3 month | Defined Contribution Plan, Cost 3 month as first filed | Defined Contribution Plan, Cost 6 month | Defined Contribution Plan, Cost 6 month as first filed | Defined Contribution Plan, Cost 9 month | Defined Contribution Plan, Cost 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1.00K 10-Q · filed 2026-08-14 | $3.00K 10-Q · filed 2026-08-14 | $4.00K derived: sum of 3 quarters · filed 2026-08-14 | $16.00K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2026-03-31 | $1.00K 10-Q · filed 2026-05-13 | $3.00K derived: sum of 2 quarters · filed 2026-05-13 | $15.00K derived: sum of 3 quarters · filed 2026-05-13 | $32.00K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $14.00K derived: sum of 2 quarters · filed 2026-03-25 | $31.00K derived: sum of 3 quarters · filed 2026-08-14 | $47.00K 10-K · filed 2026-03-25 | ||
| 2025-09-30 | $12.00K 10-Q · filed 2025-11-12 | $29.00K derived: sum of 2 quarters · filed 2026-08-14 | $45.00K 10-Q · filed 2025-11-12 | $59.00K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-06-30 | $17.00K 10-Q · filed 2026-08-14 | $33.00K 10-Q · filed 2026-08-14 | $47.00K derived: sum of 3 quarters · filed 2026-08-14 | $63.00K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-03-31 | $16.00K 10-Q · filed 2026-05-13 | $30.00K derived: sum of 2 quarters · filed 2026-05-13 | $46.00K derived: sum of 3 quarters · filed 2026-05-13 | $61.00K derived: sum of 4 quarters · filed 2026-05-13 | ||
| 2024-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $30.00K derived: sum of 2 quarters · filed 2026-03-25 | $45.00K derived: sum of 3 quarters · filed 2026-03-25 | $45.00K 10-K · filed 2026-03-25 | ||
| 2024-09-30 | $16.00K 10-Q · filed 2025-11-12 | $31.00K derived: sum of 2 quarters · filed 2025-11-12 | $31.00K 10-Q · filed 2025-11-12 | |||
| 2024-06-30 | $15.00K 10-Q · filed 2025-08-13 | $15.00K 10-Q · filed 2025-08-13 | ||||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-12 | |||||
| 2023-12-31 | $65.00K 10-K · filed 2025-03-27 | |||||
| 2022-12-31 | $236.00K 20-F · filed 2023-04-18 | |||||
| 2021-12-31 | $91.00K derived: 20-F 12 month − 6-K 9 month · filed 2023-04-18 | $177.00K derived: sum of 2 quarters · filed 2023-04-18 | $198.00K derived: sum of 3 quarters · filed 2023-04-18 | $303.00K 20-F · filed 2023-04-18 | ||
| 2021-09-30 | $86.00K 6-K · filed 2021-12-30 | $107.00K derived: sum of 2 quarters · filed 2021-12-30 | $212.00K 6-K · filed 2021-12-30 | $217.00K derived: sum of 4 quarters · filed 2023-04-18 | ||
| 2021-06-30 | $21.00K 6-K · filed 2021-09-10 | $47.00K 6-K · filed 2021-09-10 | $131.00K derived: sum of 3 quarters · filed 2023-04-18 | $165.00K derived: sum of 4 quarters · filed 2023-04-18 | ||
| 2021-03-31 | $61.00K 6-K · filed 2021-06-16 | $110.00K derived: sum of 2 quarters · filed 2023-04-18 | $144.00K derived: sum of 3 quarters · filed 2023-04-18 | $209.00K derived: sum of 4 quarters · filed 2023-04-18 | ||
| 2020-12-31 | $49.00K derived: 20-F 12 month − 6-K 9 month · filed 2023-04-18 | $83.00K derived: sum of 2 quarters · filed 2023-04-18 | $148.00K derived: sum of 3 quarters · filed 2023-04-18 | $130.00K 20-F · filed 2023-04-18 | ||
| 2020-09-30 | $34.00K 6-K · filed 2021-12-30 | $99.00K derived: sum of 2 quarters · filed 2021-12-30 | $81.00K 6-K · filed 2021-12-30 | $148.00K derived: sum of 4 quarters · filed 2022-04-14 | ||
| 2020-06-30 | $65.00K 6-K · filed 2021-09-10 | $21.00K 6-K · filed 2020-09-03 | $126.00K 6-K · filed 2021-09-10 | $47.00K 6-K · filed 2020-09-03 | $114.00K derived: sum of 3 quarters · filed 2022-04-14 | $134.00K derived: sum of 4 quarters · filed 2022-04-14 |
| 2020-03-31 | $26.00K 6-K · filed 2021-06-16 | $49.00K derived: sum of 2 quarters · filed 2022-04-14 | $69.00K derived: sum of 3 quarters · filed 2022-04-14 | $87.00K derived: sum of 4 quarters · filed 2022-04-14 | ||
| 2019-12-31 | $23.00K derived: 20-F 12 month − 6-K 9 month · filed 2022-04-14 | $43.00K derived: sum of 2 quarters · filed 2022-04-14 | $61.00K derived: sum of 3 quarters · filed 2022-04-14 | $82.00K 20-F · filed 2022-04-14 | ||
| 2019-09-30 | $20.00K 6-K · filed 2020-11-17 | $38.00K derived: sum of 2 quarters · filed 2020-11-17 | $59.00K 6-K · filed 2020-11-17 | $69.00K derived: sum of 4 quarters · filed 2021-04-30 | ||
| 2019-06-30 | $18.00K 6-K · filed 2020-09-03 | $39.00K 6-K · filed 2020-09-03 | $49.00K derived: sum of 3 quarters · filed 2021-04-30 | $61.00K derived: sum of 4 quarters · filed 2021-04-30 | ||
| 2019-03-31 | $15.00K 6-K · filed 2020-06-11 | $31.00K derived: sum of 2 quarters · filed 2021-04-30 | $43.00K derived: sum of 3 quarters · filed 2021-04-30 | $57.00K derived: sum of 4 quarters · filed 2021-04-30 | ||
| 2018-12-31 | $16.00K derived: 20-F 12 month − 6-K 9 month · filed 2021-04-30 | $28.00K derived: sum of 2 quarters · filed 2021-04-30 | $42.00K derived: sum of 3 quarters · filed 2021-04-30 | $54.00K 20-F · filed 2021-04-30 | ||
| 2018-09-30 | $12.00K 6-K · filed 2019-12-18 | $26.00K derived: sum of 2 quarters · filed 2019-12-18 | $38.00K 6-K · filed 2019-12-18 | $63.00K derived: sum of 4 quarters · filed 2020-04-30 | ||
| 2018-06-30 | $14.00K 6-K · filed 2019-09-18 | $26.00K 6-K · filed 2019-09-18 | $51.00K derived: sum of 3 quarters · filed 2020-04-30 | $55.00K derived: sum of 4 quarters · filed 2020-04-30 | ||
| 2018-03-31 | $12.00K 6-K · filed 2019-07-10 | $37.00K derived: sum of 2 quarters · filed 2020-04-30 | $41.00K derived: sum of 3 quarters · filed 2020-04-30 | $48.00K derived: sum of 4 quarters · filed 2020-04-30 | ||
| 2017-12-31 | $25.00K derived: 20-F 12 month − 6-K 9 month · filed 2020-04-30 | $29.00K derived: sum of 2 quarters · filed 2020-04-30 | $36.00K derived: sum of 3 quarters · filed 2020-04-30 | $38.00K 20-F · filed 2020-04-30 | ||
| 2017-09-30 | $4.00K 6-K · filed 2017-11-09 | $11.00K derived: sum of 2 quarters · filed 2018-10-23 | $13.00K 6-K · filed 2017-11-09 | $30.00K derived: sum of 4 quarters · filed 2019-04-30 | ||
| 2017-06-30 | $7.00K 6-K · filed 2018-10-23 | $15.00K 6-K · filed 2018-10-23 | $26.00K derived: sum of 3 quarters · filed 2019-04-30 | $30.00K derived: sum of 4 quarters · filed 2019-04-30 | ||
| 2017-03-31 | $8.00K 6-K · filed 2018-06-21 | $19.00K derived: sum of 2 quarters · filed 2019-04-30 | $23.00K derived: sum of 3 quarters · filed 2019-04-30 | |||
| 2016-12-31 | $11.00K derived: 20-F 12 month − 6-K 9 month · filed 2019-04-30 | $15.00K derived: sum of 2 quarters · filed 2019-04-30 | $22.00K 20-F · filed 2019-04-30 | |||
| 2016-09-30 | $4.00K 6-K · filed 2017-11-09 | $11.00K 6-K · filed 2017-11-09 | ||||
| 2015-12-31 | $12.00K 20-F · filed 2018-04-03 | |||||
| 2014-12-31 | $0.00 20-F · filed 2017-04-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |